Cardiac-Stem-Cells Coronary bypass surgery Restoring adequate blood flow to the heart muscle in people with heart failure and significant coronary artery disease is strongly associated with improved survival, some research showing up to 75% survival rates over 5 years. A stem cell study indicated that using autologous cardiac stem cells as a regenerative approach for the human heart (after a heart attack) has great potential. American Heart Association practice guidelines recommend implantable cardioverter-defibrillator (ICD) use in those with<unk>  (40 days post-MI) that are (NYHA) New York Heart Association functional class I. A LVEF measurement (simply called LVEF alone among cardiologists) of greater than (>) 30% is often used to differentiate primary from<unk> , and as a prognostic indicator. A 2004 study showed the patients in that study who underwent ventricular restoration as well as a coronary artery bypass achieved greater postoperative LVEF than with the latter surgery alone. Severe cases are treated with heart transplantation.
Ischemic cardiomyopathy
Dilated cardiomyopathy
Alcoholic cardiomyopathy
Amyloid cardiomyopathy
Arrhythmogenic cardiomyopathy
Restrictive cardiomyopathy
Noncompaction cardiomyopathy
Diabetic cardiomyopathy